Prevalencia de neuropatía periférica en diabéticos tipo 2 en el primer nivel de atención

Background: Neuropathy is a common complication of diabetic patients. Aim: To determine the prevalence of diabetic peripheral neuropathy in Type 2 diabetic patients attended at a family medicine unit. Material and Methods: Cross-sectional assessment of 348 type 2 diabetic patients aged 34-89 years (...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ibarra R,Carlos Tomás, Rocha L,José de Jesús, Hernández O,Raúl, Nieves R,Rene Efrén, Leyva J,Rafael
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2012
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872012000900004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872012000900004
record_format dspace
spelling oai:scielo:S0034-988720120009000042013-01-02Prevalencia de neuropatía periférica en diabéticos tipo 2 en el primer nivel de atenciónIbarra R,Carlos TomásRocha L,José de JesúsHernández O,RaúlNieves R,Rene EfrénLeyva J,Rafael Diabetes mellitus, type 2 Diabetic neuropathies Diagnostic techniques neurological Prevalence Michigan Neuropathy Screening Instrument Background: Neuropathy is a common complication of diabetic patients. Aim: To determine the prevalence of diabetic peripheral neuropathy in Type 2 diabetic patients attended at a family medicine unit. Material and Methods: Cross-sectional assessment of 348 type 2 diabetic patients aged 34-89 years (60% females) with a disease duration of 5 to 15 years. Peripheral neurological status was evaluated using The Michigan Neuropathy Screening Instrument, a tool that includes a self-assessment of symptoms and a physical examination. Results: Diabetic neuropathy was found in 240patients (69%). The prevalence in males and females was 72 and 67% respectively. The prevalence in patients with a disease duration of 5, 10 and 15 years, was 59, 69 and 77%, respectively. Fifty percent of patients with neuropathy complained of dry skin, 2% had ulcers, 43% had an abnormal perception of vibration and 29% had an abnormal monofilament test. Conclusions: The overall prevalence of peripheral neuropathy in this group of patients was 69% and was directly associated with the duration of the disease.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.140 n.9 20122012-09-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872012000900004es10.4067/S0034-98872012000900004
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Diabetes mellitus, type 2
Diabetic neuropathies
Diagnostic techniques
neurological
Prevalence
Michigan Neuropathy Screening Instrument
spellingShingle Diabetes mellitus, type 2
Diabetic neuropathies
Diagnostic techniques
neurological
Prevalence
Michigan Neuropathy Screening Instrument
Ibarra R,Carlos Tomás
Rocha L,José de Jesús
Hernández O,Raúl
Nieves R,Rene Efrén
Leyva J,Rafael
Prevalencia de neuropatía periférica en diabéticos tipo 2 en el primer nivel de atención
description Background: Neuropathy is a common complication of diabetic patients. Aim: To determine the prevalence of diabetic peripheral neuropathy in Type 2 diabetic patients attended at a family medicine unit. Material and Methods: Cross-sectional assessment of 348 type 2 diabetic patients aged 34-89 years (60% females) with a disease duration of 5 to 15 years. Peripheral neurological status was evaluated using The Michigan Neuropathy Screening Instrument, a tool that includes a self-assessment of symptoms and a physical examination. Results: Diabetic neuropathy was found in 240patients (69%). The prevalence in males and females was 72 and 67% respectively. The prevalence in patients with a disease duration of 5, 10 and 15 years, was 59, 69 and 77%, respectively. Fifty percent of patients with neuropathy complained of dry skin, 2% had ulcers, 43% had an abnormal perception of vibration and 29% had an abnormal monofilament test. Conclusions: The overall prevalence of peripheral neuropathy in this group of patients was 69% and was directly associated with the duration of the disease.
author Ibarra R,Carlos Tomás
Rocha L,José de Jesús
Hernández O,Raúl
Nieves R,Rene Efrén
Leyva J,Rafael
author_facet Ibarra R,Carlos Tomás
Rocha L,José de Jesús
Hernández O,Raúl
Nieves R,Rene Efrén
Leyva J,Rafael
author_sort Ibarra R,Carlos Tomás
title Prevalencia de neuropatía periférica en diabéticos tipo 2 en el primer nivel de atención
title_short Prevalencia de neuropatía periférica en diabéticos tipo 2 en el primer nivel de atención
title_full Prevalencia de neuropatía periférica en diabéticos tipo 2 en el primer nivel de atención
title_fullStr Prevalencia de neuropatía periférica en diabéticos tipo 2 en el primer nivel de atención
title_full_unstemmed Prevalencia de neuropatía periférica en diabéticos tipo 2 en el primer nivel de atención
title_sort prevalencia de neuropatía periférica en diabéticos tipo 2 en el primer nivel de atención
publisher Sociedad Médica de Santiago
publishDate 2012
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872012000900004
work_keys_str_mv AT ibarrarcarlostomas prevalenciadeneuropatiaperifericaendiabeticostipo2enelprimerniveldeatencion
AT rochaljosedejesus prevalenciadeneuropatiaperifericaendiabeticostipo2enelprimerniveldeatencion
AT hernandezoraul prevalenciadeneuropatiaperifericaendiabeticostipo2enelprimerniveldeatencion
AT nievesrreneefren prevalenciadeneuropatiaperifericaendiabeticostipo2enelprimerniveldeatencion
AT leyvajrafael prevalenciadeneuropatiaperifericaendiabeticostipo2enelprimerniveldeatencion
_version_ 1718436646958923776